IT1262479B - Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine. - Google Patents

Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine.

Info

Publication number
IT1262479B
IT1262479B ITFI930143A ITFI930143A IT1262479B IT 1262479 B IT1262479 B IT 1262479B IT FI930143 A ITFI930143 A IT FI930143A IT FI930143 A ITFI930143 A IT FI930143A IT 1262479 B IT1262479 B IT 1262479B
Authority
IT
Italy
Prior art keywords
diseases
relaxin
vessels
coagulation
platelet aggregation
Prior art date
Application number
ITFI930143A
Other languages
English (en)
Inventor
Mario Bigazzi
Original Assignee
Mario Bigazzi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mario Bigazzi filed Critical Mario Bigazzi
Priority to ITFI930143A priority Critical patent/IT1262479B/it
Publication of ITFI930143A0 publication Critical patent/ITFI930143A0/it
Priority to CA002145515A priority patent/CA2145515A1/en
Priority to DE69434777T priority patent/DE69434777T2/de
Priority to US08/403,878 priority patent/US5952296A/en
Priority to PCT/IT1994/000124 priority patent/WO1995003822A2/en
Priority to EP94923052A priority patent/EP0675732B1/en
Publication of ITFI930143A1 publication Critical patent/ITFI930143A1/it
Application granted granted Critical
Publication of IT1262479B publication Critical patent/IT1262479B/it

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La relassina è risultata efficace in farmaci destinati alla dilatazione di vasi sanguigni, al controllo di malattie trombotiche, alla correzione di alterazioni della funzione vasale in organi umani, quali i corpi cavernosi del pene, all'incremento della produzione e/o liberazione di nitrossido, alla riduzione delle sintesi e/o della liberazione di fibrinogeno circolante.
ITFI930143A 1993-07-27 1993-07-27 Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine. IT1262479B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITFI930143A IT1262479B (it) 1993-07-27 1993-07-27 Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine.
CA002145515A CA2145515A1 (en) 1993-07-27 1994-07-26 Use of relaxin as therapeutic or preventing agent
DE69434777T DE69434777T2 (de) 1993-07-27 1994-07-26 Verwendung von Relaxin zur Herstellung von therapeutischer Mittel
US08/403,878 US5952296A (en) 1993-07-27 1994-07-26 Method of using relaxin as therapeutic or preventing agent
PCT/IT1994/000124 WO1995003822A2 (en) 1993-07-27 1994-07-26 Use of relaxin as therapeutic or preventing agent
EP94923052A EP0675732B1 (en) 1993-07-27 1994-07-26 Use of relaxin in the manufacture of therapeutic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI930143A IT1262479B (it) 1993-07-27 1993-07-27 Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine.

Publications (3)

Publication Number Publication Date
ITFI930143A0 ITFI930143A0 (it) 1993-07-27
ITFI930143A1 ITFI930143A1 (it) 1995-01-27
IT1262479B true IT1262479B (it) 1996-06-28

Family

ID=11350556

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI930143A IT1262479B (it) 1993-07-27 1993-07-27 Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine.

Country Status (1)

Country Link
IT (1) IT1262479B (it)

Also Published As

Publication number Publication date
ITFI930143A1 (it) 1995-01-27
ITFI930143A0 (it) 1993-07-27

Similar Documents

Publication Publication Date Title
WO1988006026A3 (en) Internal prosthesis for the substitution of a part of the human body particularly in vascular surgery
DE69126205D1 (en) Oxidationsresistente analoga des thrombomodulins
Langford et al. All-cause mortality in the Hypertension Detection and Follow-up Program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality
AU3275689A (en) Process for stabilizing human albumin solutions and the solution obtained
SE9702860D0 (sv) New use
AU694973B2 (en) Ultra sound method
IL96415A0 (en) Oral composition for the treatment of inflammatory bowel diseases
OA07291A (fr) Gilet orthopédique de soutien et de contention dans le traitement des traumatisés et des opérés de l'épaule, de la ceinture scapulaire et du membre supérieur.
BR0309595A (pt) Injeção produzida a partir de ixeris sonchifolia hance para o tratamento de doenças vasculares cardiocerebrais e doenças de fundo, e método para a produção da mesma
KR900002802A (ko) 면역억제제로서의 트랜스글루타미나제의 용도
FI952593A0 (fi) Hyytymistä estävä aine
ES2085326T3 (es) Activador de plasminogeno salivar del murcielago vampiro vpa-alfa1.
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
IT1262479B (it) Impiego della relassina nelle malattie della circolazione,dei vasi, della coagulazione e della aggregazione delle piastrine.
ATE382378T1 (de) Implantatmaterial
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
SMITH Subjective experiences during a 32-year period after resurfacing of hands for severe and acute radiation burns
Kakkar Risk factors for secondary venous thromboembolism: Where, when, why and in whom
MacKay A Clinical Effect of Venostasis after 11 Years of Growth: A Case Report.
Kustos et al. Changes in connective tissue metabolism due to bone fractures in children aged 10--14 years. II. Effects of the type and localisation of fracture on the urinary excretion of hydroxyproline and glycosaminoglycans
Upendra et al. Traumatic Arteriovenous Fistula of the Scalp-Case Reports
EP0485217A3 (en) Hydantoin derivatives, and their use in preventing and treating diabetic complications and circulatory organ diseases
Kondo Clinical and experimental studies on the continuous pelvic irrigation method using normal saline containing antibiotics; with special references to the application of this method to the kidney after nephrolithotomy in cases of staghorn calculi (author's transl)
UA34378A (uk) Спосіб лікування перелому надколінника
Avrutskiĭ et al. Clinical picture and course of the neuroleptic malignant syndrome (acute febrile neuroleptic encephalopathy)

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19980730